相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SCN1A splice variants exhibit divergent sensitivity to commonly used antiepileptic drugs
Christopher H. Thompson et al.
EPILEPSIA (2011)
CYP2C9☆1B Promoter Polymorphisms, in Linkage with CYP2C19☆2, Affect Phenytoin Autoinduction of Clearance and Maintenance Dose
Amarjit S. Chaudhry et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Sodium channel gene family: epilepsy mutations, gene interactions and modifier effects
Miriam H. Meisler et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Molecular Model of Anticonvulsant Drug Binding to the Voltage-Gated Sodium Channel Inner Pore
Gregory M. Lipkind et al.
MOLECULAR PHARMACOLOGY (2010)
In vitro concentration dependent transport of phenytoin and phenobarbital, but not ethosuximide, by human P-glycoprotein
Chunbo Zhang et al.
LIFE SCIENCES (2010)
Evaluation of transport of common antiepileptic drugs by human multidrug resistance-associated proteins (MRP1, 2 and 5) that are overexpressed in pharmacoresistant epilepsy
Carlos Luna-Tortos et al.
NEUROPHARMACOLOGY (2010)
COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats
Erwin A. van Vliet et al.
NEUROPHARMACOLOGY (2010)
Maternal EPHX1 polymorphisms and risk of phenytoin-induced congenital malformations
Elizabeth M. Azzato et al.
PHARMACOGENETICS AND GENOMICS (2010)
Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese
Shuen-Iu Hung et al.
PHARMACOGENOMICS (2010)
Genetic polymorphisms in sex hormone metabolizing genes and drug response in women with epilepsy
Sandeep Grover et al.
PHARMACOGENOMICS (2010)
Influence of CYP2C9 Genetic Polymorphism and Undernourishment on Plasma-Free Phenytoin Concentrations in Epileptic Patients
Kesavan Ramasamy et al.
THERAPEUTIC DRUG MONITORING (2010)
Polymorphism of the MDR1/ABCB1 C3435T drug-transporter and resistance to anticonvulsant drugs: A meta-analysis
Facundo Garcia Bournissen et al.
EPILEPSIA (2009)
CYP2C9, CYP2C19, and ABCB1 Genotype and Hospitalization for Phenytoin Toxicity
Sean Hennessy et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B*1502 allele in Thai population
Chaichon Locharernkul et al.
EPILEPSIA (2008)
Several major antiepileptic drugs are substrates for human P-glycoprotein
Carlos Luna-Tortos et al.
NEUROPHARMACOLOGY (2008)
Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs
Chin-Chuan Hung et al.
PHARMACOGENETICS AND GENOMICS (2008)
Multidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expression
Patrick Kwan et al.
PHARMACOGENETICS AND GENOMICS (2008)
Stereoselective glucuronidation of 5-(4'-hydroxyphenyl)-5phenylhydantoin by human UDP-Glucuronosyltransferase (UGT) 1A1, UGT1A9, and UGT2B15: Effects of UGT-UGT interactions
Miki Nakajima et al.
DRUG METABOLISM AND DISPOSITION (2007)
Nova2 interacts with a cis-acting polymorphism to influence the proportions of drug-responsive splice variants of SCN1A
Erin L. Heinzen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
A common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dose
Sarah K. Tate et al.
PHARMACOGENETICS AND GENOMICS (2006)
Voltage-gated sodium channels: Action players with many faces
Tamara T. Koopmann et al.
ANNALS OF MEDICINE (2006)
Paradoxical urinary phenytoin metabolite (S)/(R) ratios in CYP2C19*1/*2 patients
Upendra A. Argikar et al.
EPILEPSY RESEARCH (2006)
P4502C18 catalyzes the metabolic bioactivation of phenytoin
RT Kinobe et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
CYP2C9, CYP2C19, ABCB1 (MDR1) genetic polymorphisms and phenytoin metabolism in a Black Beninese population
AC Allabi et al.
PHARMACOGENETICS AND GENOMICS (2005)
Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin
SK Tate et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity
H Potschka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1
A Siddiqui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
分享论文
